Form 4 for FTH Faeth Therapeutics, Inc.
Accepted 2023-09-13 00:00:00 ET · period of report 2023-09-11 · accession 0001209191-23-049192 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-09-13 | 2023-09-11 | FTH | Celebi John | Pres, CEO, Dir | P - Purchase | $0.85 | +500 | 111.3K | +0.5% | +$425 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-09-11 | P | A | 500 | $0.85 | 111,311 | D | — | — |